Alector (ALEC) Revenue & Revenue Breakdown
Alector Revenue Highlights
Latest Revenue (Y)
$97.06M
Latest Revenue (Q)
$15.08M
Main Segment (Y)
Phase Three License
Main Geography (Y)
Phase Three License
Alector Revenue by Period
Alector Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $97.06M | -27.36% |
| 2022-12-31 | $133.62M | -35.48% |
| 2021-12-31 | $207.09M | 881.54% |
| 2020-12-31 | $21.10M | -0.57% |
| 2019-12-31 | $21.22M | -23.33% |
| 2018-12-31 | $27.68M | 641.02% |
| 2017-12-31 | $3.73M | 797.84% |
| 2016-12-31 | $416.00K | - |
Alector generated $97.06M in revenue during NA 2023, up -27.36% compared to the previous quarter, and up 350.70% compared to the same period a year ago.
Alector Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $15.08M | -5.10% |
| 2024-03-31 | $15.89M | 4.63% |
| 2023-12-31 | $15.19M | 66.76% |
| 2023-09-30 | $9.11M | -83.80% |
| 2023-06-30 | $56.21M | 239.68% |
| 2023-03-31 | $16.55M | 14.61% |
| 2022-12-31 | $14.44M | -2.77% |
| 2022-09-30 | $14.85M | -81.40% |
| 2022-06-30 | $79.85M | 226.27% |
| 2022-03-31 | $24.47M | 74.89% |
| 2021-12-31 | $13.99M | -92.33% |
| 2021-09-30 | $182.41M | 2677.30% |
| 2021-06-30 | $6.57M | 59.81% |
| 2021-03-31 | $4.11M | -15.31% |
| 2020-12-31 | $4.85M | -17.80% |
| 2020-09-30 | $5.90M | 86.25% |
| 2020-06-30 | $3.17M | -55.79% |
| 2020-03-31 | $7.17M | 19.50% |
| 2019-12-31 | $6.00M | 122.59% |
| 2019-09-30 | $2.70M | -61.02% |
| 2019-06-30 | $6.92M | 23.41% |
| 2019-03-31 | $5.61M | -38.71% |
| 2018-12-31 | $9.14M | 40.63% |
| 2018-09-30 | $6.50M | -8.52% |
| 2018-06-30 | $7.11M | 44.49% |
| 2018-03-31 | $4.92M | 60.84% |
| 2017-12-31 | $3.06M | 1899.35% |
| 2017-09-30 | $153.00K | -41.49% |
| 2017-06-30 | $261.50K | - |
| 2017-03-31 | $261.50K | - |
Alector generated $15.08M in revenue during Q2 2024, up -5.10% compared to the previous quarter, and up 91.14% compared to the same period a year ago.
Alector Revenue Breakdown
Alector Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 21 |
|---|---|
| Phase Three License | $173.40M |
Alector's latest annual revenue breakdown by segment (product or service), as of Dec 21: Phase Three License (100.00%).
Quarterly Revenue by Product
| Product/Service | Sep 21 |
|---|---|
| Phase Three License | $173.40M |
Alector's latest quarterly revenue breakdown by segment (product or service), as of Sep 21: Phase Three License (100.00%).
Alector Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 21 |
|---|---|
| Phase Three License | $173.40M |
Alector's latest annual revenue breakdown by geography, as of Dec 21: Phase Three License (100.00%).
Quarterly Revenue by Country
| Country | Sep 21 |
|---|---|
| Phase Three License | $173.40M |
Alector's latest quarterly revenue breakdown by geography, as of Sep 21: Phase Three License (100.00%).
Alector Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ALEC | Alector | $97.06M | $15.08M |
| RVMD | Revolution Medicines, Inc. Warrant | $11.58M | - |
| STOK | Stoke Therapeutics | $8.78M | $4.89M |
| FIXX | Q32 Bio | $1.16M | - |
| BCEL | Atreca | $770.00K | $80.00K |
| BDTX | Black Diamond Therapeutics | - | - |
| CABA | Cabaletta Bio | - | - |
| PASG | Passage Bio | - | - |
| LRMR | Larimar Therapeutics | - | - |
| GLUE | Monte Rosa Therapeutics | - | $4.70M |